Effects of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Post-exercise Blood Lactate and Excessive Post-exercise Oxygen Consumption (EPOC)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by The Hong Kong Polytechnic University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
The Hong Kong Polytechnic University
Information provided by:
The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT01102634
First received: April 8, 2010
Last updated: April 12, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study aims to investigate the effect of Acu-TENS on post-exercise blood lactate level and EPOC
| Condition | Intervention |
|---|---|
|
Healthy Subjects |
Device: Transcutaneous electrical nerve stimulation (TENS) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by The Hong Kong Polytechnic University:
Primary Outcome Measures:
- Blood lactate level [ Time Frame: Before exercise ] [ Designated as safety issue: No ]Finger pick method - measured by Lactate Plus (Nova Biomedical, USA)
- Blood lactate level [ Time Frame: Immediately post exercise ] [ Designated as safety issue: No ]Finger pick method - measured by Lactate Plus (Nova Biomedical, USA)
- Blood lactate level [ Time Frame: 15 minutes post exercise ] [ Designated as safety issue: No ]Finger pick method - measured by Lactate Plus (Nova Biomedical, USA)
- Oxygen consumption [ Time Frame: Measurements continued during exercise and until heart rate returned to baseline ] [ Designated as safety issue: No ]measured by K4b2 (Cosmed, Italy)
Secondary Outcome Measures:
- Heart rate [ Time Frame: Measurements continued during exercise and until heart rate returned to baseline ] [ Designated as safety issue: No ]measured by Polar heart rate monitor (RS800CX, Polar Electro, Finland)
| Estimated Enrollment: | 20 |
| Study Start Date: | April 2010 |
| Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Acu-TENS
Application of TENS over acupuncture points
|
Device: Transcutaneous electrical nerve stimulation (TENS)
Application of TENS over acupuncture points
|
|
Placebo Comparator: Placebo-TENS
Application of Acu-TENS but with no electricity
|
Device: Transcutaneous electrical nerve stimulation (TENS)
Placebo
|
Eligibility| Ages Eligible for Study: | 20 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- with normal health (no known history of cardiovascular, pulmonary, metabolic or musculoskeletal diseases)
Exclusion Criteria:
- unable to communicate and follow the exercise procedures
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01102634
Contacts
| Contact: Alice Jones, PhD, FACP | (852) 27666749 | alice.jones@polyu.edu.hk |
Locations
| China, Hong Kong | |
| Cardiopulmonary and Exercise Physiology Laboratory, The Hong Kong Polytechnic University | Recruiting |
| Hong Kong, Hong Kong, China | |
| Contact: Alice Jones, PhD, FACP (852)27666749 alice.jones@polyu.edu.hk | |
| Principal Investigator: Alice Jones, PhD, FACP | |
Sponsors and Collaborators
The Hong Kong Polytechnic University
Investigators
| Principal Investigator: | Alice Jones, PhD, FACP | The Hong Kong Polytechnic University |
More Information
No publications provided
| Responsible Party: | Prof. Alice Jones, The Hong Kong Polytechnic University |
| ClinicalTrials.gov Identifier: | NCT01102634 History of Changes |
| Other Study ID Numbers: | HSEARS20100407006 |
| Study First Received: | April 8, 2010 |
| Last Updated: | April 12, 2010 |
| Health Authority: | Hong Kong: Ethics Committee |
ClinicalTrials.gov processed this record on May 19, 2013